Brandenburg Physicians Express Concerns Over Expanded Pharmacy Services

The Brandenburg Association of Statutory Health Insurance Physicians (KVBB) has expressed significant reservations regarding the new responsibilities assigned to public pharmacies under the recently enacted Pharmacy Supply and Development Act (ApoVWG). The legislation, which was officially published and is set to take effect on July 2, introduces several expanded roles for pharmacies, including venous blood sampling for diagnostic purposes, offering rapid diagnostic tests, screening for cardiovascular and diabetes risks, and, under certain circumstances, dispensing prescription medications without a prior prescription.

According to the KVBB, these new tasks, while designed to alleviate pressure on the healthcare system, may not have the intended effect. The association argues that such measures do not represent a pragmatic relief for medical practices but instead pose risks due to the overlap and blurring of professional boundaries between pharmacists and physicians.

Key among the KVBB's concerns is the provision allowing pharmacies to conduct venous blood draws for diagnostics. While this is now legally permitted under an amendment to the ApoVWG, the association emphasizes that the training and professional focus of pharmacists differ fundamentally from those of physicians. The KVBB maintains that comprehensive patient assessments often require clinical experience, physical examinations, and diagnostic acumen that go beyond algorithm-based or rapid testing approaches commonly used in pharmacies.

The association also points out that the expansion of pharmacy services comes at a time when funding for medical practices is being reduced. This, they argue, shifts resources away from primary care doctors, potentially undermining the overall quality and safety of patient care. Instead of streamlining healthcare delivery, the KVBB warns that these changes could result in increased complexity, additional work for all providers, and greater risk of misjudgments in diagnosis and treatment.

Further concerns were raised about the fragmentation of the patient care pathway. The KVBB believes that the separation of diagnostic tasks between pharmacists and physicians could disrupt the established chain of diagnostic responsibility. This fragmentation, they contend, may lead to patients being referred between multiple points in the healthcare system, resulting in duplicated efforts and reducing the time available for direct patient care.

The new law's intention to integrate pharmacies more closely into primary healthcare is part of broader reforms aimed at addressing the pressures on Germany's healthcare system. Demographic changes and increasing demand for medical consultations and treatments have prompted policymakers to consider new models of care. By granting pharmacies expanded roles, the goal is to improve accessibility and efficiency in healthcare delivery, especially in underserved areas.

However, professional groups such as the KVBB continue to emphasize the importance of maintaining clear professional boundaries. They argue that while pharmacists play an essential role in the supply and management of medications, the expertise required for medical diagnoses and treatment planning should remain within the domain of physicians. The KVBB asserts that any attempt to redistribute diagnostic and therapeutic responsibilities must be carefully evaluated to avoid unintended consequences for patient safety and system efficiency.

The debate over the ApoVWG and its implications for healthcare roles is ongoing. While some industry observers highlight the potential for pharmacies to act as accessible health hubs, others caution that complex diagnostic and therapeutic processes require the specialized training and clinical judgment unique to physicians. As the new legislation takes effect, stakeholders across the healthcare sector will be closely monitoring its impact on patient care, professional collaboration, and the overall functioning of the health system.